This compound is a benzimidazole derivative featuring an ethyl ester and a cyano-substituted biphenyl moiety. It is primarily recognized as a pharmaceutical intermediate, with its crystal structure reported in the scientific literature.
Content scope: Information here supports chemical identification and industrial supply, research, and manufacturing contexts. It is not a therapeutic claim, medical advice, or drug-use instructions.
Sourcing this compound?
Post a free purchase request — no account needed. It reaches suppliers of this product, and replies go straight to your inbox.
Methyl 1-[(2'-cyanobiphenyl-4-yl)methyl]-2-ethoxy-1H-benzimidazole-7-carboxylate
pharmaceutical intermediate
Ethyl candesartan
pharmaceutical intermediate
Trityl candesartan
pharmaceutical intermediate
16α-hydroxyprednisolone
pharmaceutical intermediate
2-(7-Methoxy-1-naphthyl)ethylamine hydrochloride
pharmaceutical intermediate
2-Ethoxy-1-[[2'-[(hydroxyamino)iminomethyl][1,1'-biphenyl]-4-yl]methyl]-1H-benzimidazole-7-carboxylic acid ethyl ester
pharmaceutical intermediate
2-Ethoxy-1-[[2'-[(hydroxyamino)iminomethyl][1,1'-biphenyl]-4-yl]methyl]-1H-benzimidazole-7-carboxylic acid methyl ester
pharmaceutical intermediate
6-des(1-methyl-2-benzimidazolyl)-6-carboxy telmisartan
pharmaceutical raw material
ethyl 3-[[4-(2-cyanophenyl)phenyl]methyl]-2-ethoxybenzimidazole-4-carboxylate
GYTTUVXCCHRIBA-UHFFFAOYSA-N
CCOC1=NC2=CC=CC(=C2N1CC3=CC=C(C=C3)C4=CC=CC=C4C#N)C(=O)OCC
—
Sourcing this compound?
Post a free purchase request — no account needed. It reaches suppliers of this product, and replies go straight to your inbox.